BioLegend specializes in advanced technologies for life sciences research, particularly in the fields of immunology, neuroscience, oncology, and stem cell research. Their TotalSeq™ PhenoCyte kit provides a comprehensive solution for high-throughput, single-cell protein analysis, enabling researchers to gain insights into cellular functions at an unprecedented level. Additionally, BioLegend's Spark PLUS™ antibody conjugates utilize proprietary technology to enhance the brightness of fluorophores, improving the visibility of targets in various assays. Their Direct-Blot™ antibodies streamline western blotting processes by allowing primary antibodies to be directly conjugated to HRP, thus simplifying experimental workflows and reducing costs.

In the realm of clinical applications, BioLegend offers In Vitro Diagnostic (IVD) and Analyte Specific Reagent (ASR) products that meet stringent quality standards for use in clinical laboratories. Their extensive portfolio includes custom reagents, LEGENDplex™ immunoassays for multiplex analysis, and a wide range of antibodies and recombinant proteins tailored for specific research needs. BioLegend's commitment to innovation is evident in their partnerships with leading organizations, such as The Michael J. Fox Foundation, to advance research in neurodegenerative diseases and other critical areas. Their technologies not only facilitate the identification and characterization of cell populations but also support the development of novel therapeutic strategies.

United States

BioLegend develops antibodies and reagents for biomedical research, manufactured in our state-of-the-art facility in San Diego, CA.

BioLegend

Company Details